Company Filing History:
Years Active: 1991-1994
Title: The Innovations of Setsuyoshi Uetsuki
Introduction
Setsuyoshi Uetsuki is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and novel pharmaceutical compounds. With a total of 2 patents to his name, Uetsuki's work has the potential to impact medical treatments and therapies.
Latest Patents
Uetsuki's latest patents include a monoclonal antibody specific for human interleukin-1.beta. This invention provides a monoclonal antibody characterized by its specific reactivity on human IL-1.beta., along with a process for producing the antibody. Additionally, he has developed a novel pyrazinoxide compound of NF-1616-904, which is prepared by hydrolyzing an intermediate compound separated from a culture broth of a microorganism belonging to the genus Thielavia. This compound possesses biological and pharmacological activities, making it a useful agent for preventing and treating diseases caused by superoxide radicals and nephritis.
Career Highlights
Setsuyoshi Uetsuki is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the field of pharmaceuticals. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Uetsuki has collaborated with notable colleagues such as Osamu Sato and Yasuo Nakayama, further enhancing the impact of his research and inventions.
Conclusion
Setsuyoshi Uetsuki's contributions to biotechnology and pharmaceuticals exemplify the spirit of innovation. His patents reflect a dedication to addressing critical health challenges through scientific advancement.